// App-Quantinova.ai

S221 : INTER-B NHL RITUX 2010 TRIAL FOR CHILDREN/ADOLESCENTS WITH HIGH-RISK MATURE B-CELL NON-HODGKIN’S LYMPHOMA/ACUTE LEUKAEMIA: SAFETY AND EFFICACY IN PATIENTS TREATED WITH RITUXIMAB AND LMB CHEMOTHERAPY.

Researchers

Presenter

  • Veronique Minard-Colin

Principal Investigators

  • G. A. Amos Burke

  • Sarah Alexander

  • Rafael Delgado

  • Salvatore Buffardi

  • Anne Uyttebroeck

  • Catherine Bollard

  • Jzsef Zsiros

  • Monika Csoka

  • Bernarda Kazanowska

  • Alan K Chiang

  • Arnaud Verschuur

  • Rodney R. Miles

  • Andrew Wotherspoon

  • Donald A. Barkauskas

  • Keith Wheatley

  • Gilles Vassal

  • Peter Adamson

  • Thomas G. Gross

  • Catherine Patte

  • Marta Pillon

Medical Centers

  • Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada

  • Department of Paediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Wroclaw, Poland

  • Global Head, Oncology Development &amp

  • Paediatric Haematology Oncology Division, University of Padova, Padova, Italy

  • Department of Pediatric and Adolescent Oncology,Gustave Roussy,Villejuif,France

  • 15. Pediatric Hematology and Oncology,Semmelweis University,Budapest,Hungary

  • Pediatric Oncology & Hematology,University Hospitals Leuven,Leuven,Belgium

  • Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France

  • Pediatric and Adolescent hematology and Oncology,Gustave Roussy,Villejuif,France

  • Department of Paediatric Haematology, Oncology and Palliative Care,cambridge university hospitals NHS Foundation Trust,Cambridge,United Kingdom

  • Pediatric Hematology and Oncology,A.O.R.N. Santobono–Pausilipon,Napoli,Italy

  • Center for Cancer and Immunology Research,Children's National Health System and The George Washington University,Washington,United States

  • Pediatric Hematology and Oncology,La Timone, APHM,Marseille,France

  • Cancer Research UK Clinical Trials Unit,Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences,Birmingham,United Kingdom

  • Pediatric Innovation at Sanofi,Cambridge,United States

  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • Princess Máxima Center for Pediatric Oncology,Princess Máxima Center for Pediatric Oncology,Ultrecht,Netherlands

  • Pathology Department,The Royal Marsden NHS,London,United Kingdom

  • Pediatric Hematology and Oncology,University of Valencia,Valencia,Spain

  • Department of Pediatrics, Center for Cancer and Blood Diseases,Children’s Hospital Colorado,Aurora,United States

  • Department of Pathology and ARUP Laboratories,Huntsman Cancer Institute,Salt Lake City,United States

  • Department of Pediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China

Locations

  • Canada

  • Poland

  • Italy

  • France

  • Hungary

  • Belgium

  • United Kingdom

  • United States

  • Netherlands

  • Spain

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • B-Cell Non-Hodgkin Lymphoma

  • Acute Leukemia

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Lactate dehydrogenase

  • Cerebrospinal fluid

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

  • Cohort

Phase

  • III

Study Id's

  • NCT01516580

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved